Reporting combined outcomes with Trifecta and survival, continence, and potency (SCP) classification in 337 patients with prostate cancer treated with image-guided hypofractionated radiotherapy
Association of pretreatment neutrophil-to-lymphocyte ratio (NLR) and overall survival (OS) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with first-line docetaxel
Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate cancer
Radiographic progression by Prostate Cancer Working Group (PCWG)-2 criteria as an intermediate endpoint for drug development in metastatic castration-resistant prostate cancer
Detection of the index tumour and tumour volume in prostate cancer using T2-weighted and diffusion-weighted magnetic resonance imaging (MRI) alone
Multiparametric magnetic resonance imaging (MRI) and subsequent MRI/ultrasonography fusion-guided biopsy increase the detection of anteriorly located prostate cancers
Genetically adjusted prostate-specific antigen values may prevent delayed biopsies in African-American men
Fluctuation in prostate cancer gene 3 (PCA3) score in men undergoing first or repeat prostate biopsies
Survival benefit of definitive therapy in patients with clinically advanced prostate cancer: estimations of the number needed to treat based on competing-risks analysis
Quantification of skeletal metastases in castrate-resistant prostate cancer predicts progression-free and overall survival
Impact of comorbidity on health-related quality of life after prostate cancer treatment: combined analysis of two prospective cohort studies
The impact of androgen-deprivation therapy (ADT) on the risk of cardiovascular (CV) events in patients with non-metastatic prostate cancer: a population-based study
Circumcision and prostate cancer: a population-based case-control study in Montréal, Canada
Factors influencing disease progression of prostate cancer under active surveillance: a McGill University Health Center cohort
Prostate tumour volumes: evaluation of the agreement between magnetic resonance imaging and histology using novel co-registration software
External validation of the Briganti nomogram to estimate the probability of specimen-confined disease in patients with high-risk prostate cancer
Outcomes of men with an elevated prostate-specific antigen (PSA) level as their sole preoperative intermediate- or high-risk feature